A Current Perspective on the Assessment of Prevalence of Dengue Cases in a Territory Care Hospital Bangalore and Impact of Clinical Pharmacist Mediated Patient Counseling – A Prospective Study
DOI:
https://doi.org/10.22270/ajprd.v7i5.598Keywords:
Dengue shock syndrome, Febrile convulsions, Thrombocytopenia Arthralgia.Abstract
Background: Dengue is an Infectious viral disease caused by the dengue virus. Dengue fever is caused by one of four types of dengue virus. It is transmitted by “Aedes aegypti mosquito”. Symptoms include Fever, Arthralgia, Myalgia and Headache etc.,. Dengue is mosquito-borne viral illness. Fluid and electrolyte losses, dengue shock syndrome, residual brain damage, Febrile convulsions, Low platelet count, Significant bleeding, Liver damage are some of the complications of dengue fever
Aim The present hospital study aims to illustrate the frequency, distribution and case fatality of dengue fever based on the variables such as age, sex and impact of clinical pharmacist mediated patient counseling.
Objectives: To evaluate the perspectives on assessment of prevalence of the dengue fever and the impact of clinical pharmacist mediated in patient counseling.
To estimate the prevalence of dengue fever, educate and create awareness about dengue fever and prevent further complications.
Methodology: A prospective Observational study was carried out among 150 patients for a period of 4 months from June 2019 to September 2019 in ESI hospital Indiranagar, Bangalore.
Results: Dengue fever is mostly seen among the age groups between 15-55 yrs. An excess of males were found among reported dengue cases than females 54.6 % were males and 45.3% were females. High proportion of cases were reported in adult age groups (25-35 years) in both males and females, Out of 150 cases Dengue fever 89.3% , Dengue hemorrhagic fever is 7.3% and Dengue shock syndrome 3.33% is fatality rate and the outcome of dengue fever is 94.66% survival rate and 5.3% death rate.
Conclusion: The patients with Dengue fever 89.3% and other types are DHF, DSS 7.3% and 3.3% out of them patients with thrombocytopenia is 64.66% and the platelet transfusion done in 65 patients (43.33%) out of them 142 patients (94.6%) are survived and the death rate is 5.3% the early identification of complications might have increased the survival rate and decreases the mortality in Dengue fever patients.
Downloads
References
2. World Health Organization. Prevention and control of dengue and dengue haemorrhagic fever: comprehensive guidelines. WHO Regional publication, SEARO.1999; 29.
3. Halstead SB. Is there an in apparent dengue explosion Lancet 1999; 353:1100–1.
4. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis.2002; 2: 33–42
5. Workshop on case management of dengue hemorrhagic fever Bangkok, Thailand.2002..
6. Global strategy for dengue prevention and control. Geneva: World Health Organization; 2012; 16-7.
7. Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, Levi JE, et al. Dengue and Dengue Haemorrhagic Fever among adults. Clinical outcomes related to Viremia, Serotypes and Antibody response. J Infect Dis 2008; 197:817-24.
8. Lin CH, Schiøler KL, Jepsen MR, Ho CK, Li SH, Konradsen F. Dengue outbreaks in high income area, Kaohsiung city, Taiwan, 2003-2009. Emerg Infect Dis 2012; 18:1063-11.
9. S. Bhatt, P.W. Gething, O. J.Brady et al., “The global distribution and burden of dengue,” Nature.2013; 496: 504–507.
10. O. J. Brady, P. W. Gething, S. Bhatt et al., “Refining the global spatial limits of dengue virus transmission by evidence-based consensus,” PLoS Neglected Tropical Diseases.2012; 6(8):1760.
11. Centers for Disease control and prevention, National center for emerging and zoonotic infectious diseases
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.